Immunohistochemistry and Multiplex IHC Services
Our comprehensive immunohistochemistry (IHC) and multiplex IHC (mIHC) services combine scientific expertise, cutting-edge technology, and proven assay development workflows to accelerate your biomarker discovery and translational research. Whether you’re advancing early-stage studies or supporting clinical trial programs, we deliver high-quality, reproducible tissue-based data that drive confident decisions.
Our IHC and Multiplex IHC Capabilities
Expert-Driven Assay Development & Protocol Transfer
Collaborate with our experienced scientists and pathologists to develop or transfer IHC assays seamlessly into our lab environment. We optimize sensitivity, specificity, and reproducibility—ensuring your staining performs exactly as intended.
Comprehensive Biomarker Coverage
Access our extensive menu of validated biomarkers across oncology, immunology, and neuroscience. Need something unique? We’ll design and validate custom single-plex or multiplex panels with either chromogenic or immunofluorescent methods, tailored to your targets.
Advanced Multiplex IHC & Spatial Analysis
Get more data from every slide. Our multiplex IHC and immunofluorescence workflows detect multiple biomarkers simultaneously, revealing cellular co-localization, immune context, and tumor microenvironment architecture powered by digital pathology and image-analysis technologies.
From Discovery to the Clinic
From preclinical research to companion diagnostic (CDx) development, our labs operate under rigorous quality and regulatory standards. We provide complete assay validation, scoring scheme development, and clinical trial sample testing – helping you move faster from insight to impact.
Why Our Services Accelerate your Program
Technology-agnostic approach: We evaluate and select the optimal staining platform, detection chemistry and image-analysis workflow for each project rather than being tied to one vendor.
Clinical-ready lab infrastructure: Our labs meet CLIA and CAP standards, supporting preclinical through clinical/diagnostic workflows with assurance of quality and audit-readiness.
Experienced scientist-pathologist team: Benefit from assay-development experts who understand tissue biology, pathology scoring, clinical trial requirements and biomarker strategy.
Scalable and flexible engagement model: Whether you require one custom assay, high-throughput testing or multiplex panel screening, we tailor our capacity to your timeline, budget and sample volume.
Our IHC Staining Platforms
We utilize leading automated staining systems to deliver precision, consistency, and scalability for every project. Multiple platform options allow us to tailor workflows to your specific biomarker, tissue type, and study requirements, ensuring the highest quality staining and reproducible results.
- Leica Bond Rx
- Leica Bond III
- Ventana Discovery
- Ventana Benchmark Ultra
- Dako Autostainer Link 48
